Introduction
Spinal cord injury (SCI) is a severe medical condition that causes permanent loss of movement and sensation due to neuron death and severed connections. This spine damage cannot be fully healed by the body itself and current human treatments due to two major factors. First, the neurons in the spinal cord have little intrinsic ability to regenerate, and second, the injury environment becomes hostile, with inflammation, scar formation, and inhibitory molecules that block regrowth.
A possible solution that is being sought is the usage of neural stem cells (NSC). NSCs are naturally found in developing nervous systems and specific brain regions such as the subventricular and subgranular zones. Scientists believe that transplanting neural stem cells into the body can help reconstruct and heal a SCI. The goal of this study is to determine whether transplanted NSCs can rebuild connections across the injury site by building neuronal relays and cellular bridges in order to support recovery of SCIs.
Methods
This study is a review of preclinical experimental studies conducted mostly on animals such as rodents and non-human primates. The animal models were induced spinal cord injuries and treated with transplantation of neural stem cells directly into or nearby the site of injury. Growth factors and biomaterials like fibrin matrices were used to support survival and recovery. Axon growth and synapse formation was measured in order to gauge results. Electrical activity and calcium signalling in the neuron was also recorded in order to confirm a connection was formed. Lastly, behavioral tests were run to record any psychological recovery. The different studies reviewed compared different cell types, graft locations, and injury severities.
Results and Limitations
Injured axons were able to grow into stem cell grafts, a step up from normal SCI treatments. Thus proving potential in this method of treatment. The transplanted cells formed connections or synapses with the neurons and extended new axons beyond the injury site, creating new pathways that help reconnect neurons. Researchers also observed regeneration in the corticospinal tract, a key pathway responsible for voluntary movement, which is usually very difficult to repair. Nerve fibers carrying touch and pain information were able to connect with the grafts, and the transplanted neurons responded to sensory signals, suggesting some recovery of sensation. The new axons were capable of growing long distances along the spinal cord, sometimes across multiple segments, which is critical for restoring function. In several animal studies, these biological changes translated into real improvements, such as better movement and reduced pain-like behaviors. These connections were not random, motor neurons tended to connect with motor-related cells, indicating a level of organization that is essential for proper function.
Limitations:
Some limitations to the findings include that the treatments were done on animal models, which are rudimentary compared to spinal cord injuries of humans. The findings do not spell out a full restoration of function but highlighted some connections forming. More severe injuries may limit success and treatments may cause increased risk of tumor formation and increased pain. This form of treatment is still a work in progress and isn’t fully fleshed out yet, causing massive variability in outcomes of treatment.
Conclusion
Using neural stem cells could be a powerful way to help repair spinal cord injuries by rebuilding broken communication pathways in the nervous system. By forming new connections, these cells can help restore both movement and sensation, even in critical pathways like the corticospinal tract. This is especially important because there is currently no cure for spinal cord injury, and even small improvements could make a big difference in a person’s daily life.
Looking ahead, researchers are working on making this approach much more safe and effective, improving how the cells are delivered, and combining it with other treatments like rehabilitation. With continued progress, this therapy has the potential to move into clinical trials and eventually become an ideal treatment option for people living with spinal cord injuries.
